Randomised phase 3 trial of radiation plus androgen deprivation therapy with or without enzalutamide for high risk, clinically localised, prostate cancer
Primary Sponsor
Trans-Tasman Radiation Oncology Group (TROG)
Participating Centres
Current Accrual
Related Post
August 2, 2022
Celebrating and bringing radiation medicine research to the forefront at our 2022 ASM
After a hiatus from in-person events due to COVID-19
February 28, 2022
Cancer trial participant hoping to help
The RAVES trial treating prostate cancer Participating in a
